Jeffrey W. Sherman - Sep 6, 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
EVP and Chief Medical Officer
Signature
/s/ Patrick McIlvenny, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Sep 6, 2023
Transactions value $
$0
Form type
4
Date filed
9/7/2023, 04:15 PM
Previous filing
Jun 7, 2023
Next filing
Oct 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Gift $0 -2.17K -2.61% $0.00 80.9K Sep 6, 2023 See Footnote F1
holding HZNP Ordinary Shares 106K Sep 6, 2023 See Footnote F2, F3
holding HZNP Ordinary Shares 45.4K Sep 6, 2023 By Spouse F2
holding HZNP Ordinary Shares 2.66K Sep 6, 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held in the Jeffrey W. Sherman Living Trust.
F2 21,378 ordinary shares held indirectly by the reporting person were inadvertently reported on a prior Form 4 as sold on December 12, 2022 by the Jeffrey W. Sherman 2020 Gift Trust. Instead, the ordinary shares were sold by the reporting person's spouse. The reporting person's holdings on this Form 4 have been adjusted accordingly.
F3 The shares are held in the name of the Jeffrey W. Sherman 2020 Gift Trust, of which the reporting person's spouse is the Trustee.
F4 Includes 279 ordinary shares of the Issuer acquired by the reporting person on June 1, 2023 pursuant to an employee stock purchase program.